STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 7th, 2010 • Jedediah Resources Corp. • Metal mining • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of May 3, 2010, is made by and between Jedediah Resources Corp., a Nevada corporation (“Seller”), and Ola Juvkam-Wold (“Buyer”).
PROPERTY OPTION AGREEMENTProperty Option Agreement • December 12th, 2008 • Jedediah Resources Corp. • Alberta
JRE EXPLORATION LTD.., a body corporate, incorporated under the laws of Alberta and having offices located at 100 – 111, 5th Avenue S.W., Suite 304, , Calgary, Alberta, Canada;
COMMON STOCK PURCHASE WARRANT ALTEROLA BIOTECH, INC.Common Stock Purchase Warrant • August 19th, 2021 • Alterola Biotech Inc. • Metal mining • Nevada
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, EMC2 Capital, LLC, a Wyoming limited liability company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Issuance Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Alterola Biotech, Inc., a Nevada corporation (the “Company”), up to Fifteen Million (15,000,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). Holder and Company are collectively referred to herein as the “Parties” and at times each is individually referred to as a “Party.” Capitalized terms used herein and not otherwise defined herein shall have the respecti
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Delaware
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June __, 2024, is by and among Phytanix Bio, Inc., a Nevada corporation with offices located at 701 Anacapa Street, Suite C, Santa Barbara, CA 93101 (the “Company”), and each of the investors signatory hereto (individually, a “Buyer” and collectively, the “Buyers”).
Investor Rights AgreementInvestor Rights Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • New York
This Investor Rights Agreement (this “Agreement”), dated as of July 22, 2024, is among CB Holdings, Inc., a Nevada corporation (“HoldCo”), , a (the “CBRG Sponsor”), and certain shareholders of Phytanix Bio, a Nevada corporation (the “Company”) listed on Schedule A hereto (the “Company Shareholders” and, together with CBRG Sponsor, the “Holders”). Capitalized terms used but not defined herein have the meanings assigned to them in the Business Combination Agreement dated as of July 22, 2024 (as amended, supplemented, or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”), among Chain Bridge I, a Cayman Islands exempted company (“CBRG” or the “SPAC”), the Company, HoldCo, CB Merger Sub 1, a Cayman Islands exempted company (“CBRG Merger Sub”) and CB Merger Sub 2, Inc., a Nevada corporation (“Company Merger Sub”).
COMMON STOCK PURCHASE AGREEMENT Alterola Biotech, Inc. EMC2 Capital, LLCCommon Stock Purchase Agreement • August 19th, 2021 • Alterola Biotech Inc. • Metal mining • Nevada
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is entered into as of August 11, 2021 (the “Execution Date”), by and between Alterola Biotech, Inc., a Nevada corporation (the “Company”), and EMC2 Capital, LLC, a Wyoming limited liability company (the “Buyer”). Company and Buyer are collectively referred to herein as the “Parties” and at times each is individually referred to as a “Party.” Capitalized terms used herein and not otherwise defined are defined in Section 11.
SETTLEMENT AGREEMENT AND RELEASESettlement Agreement • July 18th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Delaware
REGISTRATION RIGHTS AGREEMENT Alterola Biotech, Inc. EMC2 Capital, LLCRegistration Rights Agreement • August 19th, 2021 • Alterola Biotech Inc. • Metal mining • Nevada
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”), is entered into as of August 11, 2021 (the “Execution Date”), by and between Alterola Biotech, Inc., a Nevada corporation (the “Company”), and EMC2 Capital, LLC, a Wyoming limited liability company (the “Buyer”). Company and Buyer are collectively referred to herein as the “Parties” and at times each is individually referred to as a “Party.” Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
BUSINESS COMBINATION AGREEMENT BY AND AMONG CHAIN BRIDGE I, CB HOLDINGS, INC., CB MERGER SUB 1 CB MERGER SUB 2, INC., AND PHYTANIX BIO DATED AS OF JULY 22, 2024Business Combination Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • New York
CANCELATION AGREEMENTCancelation Agreement • November 19th, 2010 • Jedediah Resources Corp. • Metal mining • New York
THIS CANCELATION AGREEMENT, dated as of 17 November, 2010 (the “Agreement”), is entered into by and among Alterola Biotech Inc., a Nevada corporation with headquarters located at 228 Hamilton Avenue, 3rd Floor, Palo Alto, CA (the “Company”) and Soren Nielsen (the “Stockholder”).
COMPANY SHAREHOLDER TRANSACTION SUPPORT AGREEMENTShareholder Agreement • August 15th, 2024 • Alterola Biotech Inc. • Medicinal chemicals & botanical products
This COMPANY SHAREHOLDER TRANSACTION SUPPORT AGREEMENT (this “Agreement”) is entered into as of ____________, by and among Chain Bridge I, a Cayman Islands exempted company (“CBRG”), Phytanix Bio, a Nevada corporation (the “Company”), and the party listed on the signature pages hereto as a “Shareholder” (the “Shareholder”). Each of CBRG, the Company and the Shareholder are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Business Combination Agreement (defined below).
AGREEMENT TO RETURN ASSETS AND SHARESAgreement to Return Assets and Shares • September 19th, 2023 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • New York
INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENTIntellectual Property Assignment Agreement • May 7th, 2010 • Jedediah Resources Corp. • Metal mining • New York
This Agreement is made this 3rd day of May, 2010 and is by and between Soren Nielsen (“Nielsen”), an individual with a principal residence at ____________________, and Jedediah Resources Corp. (“Jedediah”), a Nevada corporation with a principal place of business at 100-111 5th Avenue, S.W., Calgary, Alberta, Canada, (collectively the “Parties”).
AGREEMENT OF CONVEYANCE, TRANSFER AND ASSIGNMENT OF ASSETSAgreement of Conveyance, Transfer and Assignment of Assets • April 12th, 2017 • Alterola Biotech Inc. • Metal mining • Nevada
This Agreement of Conveyance, Transfer and Assignment of Assets (the “Agreement”) is made as of April 10, 2017, by Alterola Biotech, Inc., a Nevada corporation (“Assignor”), and Rene Lauritsen (“Assignee”).
CONSULTING AGREEMENTConsulting Agreement • April 7th, 2022 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Wyoming
This Agreement is made effective as of March 03, 2022, by and between ALTEROLA BIOTECH INC., of 47 Hamilton Square, Birkenhead, Merseyside, CH41 5AR, UNITED KINGDOM, and REB CONSULTANCY LLC, of 30 N Gould St Ste R, Sheridan, Wyoming 82801, USA and its affiliate C2 Holdings LLC (all redefined as REB).
AMENDMENT TO STOCK TRANSFER AGREEMENTStock Transfer Agreement • May 25th, 2021 • Alterola Biotech Inc. • Metal mining
This AMENDMENT TO STOCK TRANSFER AGREEMENT (this “Amendment”), effective as of May 24, 2021 (the “Effective Date”), is entered into by and between ALTEROLA BIOTECH INC., a Nevada corporation (“ALT”); and the shareholders of ABTI PHARMA LIMITED (“ABTIP”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 9th, 2021 • Alterola Biotech Inc. • Metal mining
EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of Monday, March 28, 2021, is made by and between ALTEROLA BIOTECH, INC “ABTI” a Nevada Corporation with address 47 Hamilton Square Birkenhead Merseyside , United Kingdom, CH415AR (“The Company”) and Mr. Larson Elmore (hereinafter referred to as “ The Executive”),located at 15954 Jackson Creek Parkway , Ste. 442, Monument , Colorado 80132 agrees based upon the following terms and conditions:
STOCK TRANSFER AGREEMENTStock Transfer Agreement • March 16th, 2021 • Alterola Biotech Inc. • Metal mining • Nevada
THIS STOCK TRANSFER AGREEMENT (“Transfer Agreement”) dated January 19th 2021, is made and entered into by and between ALTEROLA BIOTECH INC., a Nevada corporation (“ALT”); and the shareholders of ABTI PHARMA LIMITED (“ABTIP”) as outlined in Appendix 1, hereinafter “the Parties”.
CORPORATE MANAGEMENT SERVICES AGREEMENTCorporate Management Services Agreement • December 12th, 2008 • Jedediah Resources Corp. • Alberta
WHEREAS, Jedediah is engaged in the field of mineral exploration, and the conduct of such other activities as may be incidental or related thereto; and
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • December 29th, 2020 • Alterola Biotech Inc. • Metal mining • Nevada
EXECUTIVE EMPLOYMENT AGREEMENT (this "Agreement") , dated below and effective as of the 1st day of April, 2018 ("Effective Date"), by and between Alterola Biotech Inc a Corporation organized and existing under the laws of Nevada , (the "Company") and Rene Lauritsen (hereinafter referred to as "Executive"), whose address is Fyrremejseve 8250 Egga Denmark ,Company and Executive may be referred to collectively as "Parties" and individually as "Party".
ALTEROLA BIOTECH INC.Letter of Intent • September 1st, 2022 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Delaware
The purpose of this letter (the “Letter of Intent” or “LOI”) is to set forth: (A) the binding agreement of both parties regarding Bright Green Corporation’s acquisition of 25% of Alterola Biotech Inc., a Nevada Company traded on OTC Markets under the symbol “ABTI,” in exchange for a consideration of cash and consideration to be paid; and (B) the non-binding understanding of both parties regarding Alterola Biotech Inc.’s intent to irrevocably grant to Bright Green Corporation the right to purchase the remaining shares of Alterola Biotech Inc., on terms and conditions as set out in this Letter of Intent.
DEED OF VARIATIONDeed of Variation • August 26th, 2019 • Alterola Biotech Inc. • Metal mining
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • December 3rd, 2021 • Alterola Biotech Inc. • Medicinal chemicals & botanical products • Nevada
("Effective Date"), is entered into by and among C2 WELLNESS CORPORATION. ("Company"), a Wyoming corporation, Registered Number 2021-000974814, with an address at 30 N. Gould Street, Suite R, Sheridan, Wyoming 82801; and ALTEROLA BIOTECH INC. ("Purchaser"), a Nevada corporation, Registered Number E0460892008-3, with an address at 47 Hamilton Square, Birkenhead Merseyside CH41 SAR, United Kingdom. Seller and Purchaser shall be known separately as a "Party" and collectively as the "Parties."
Share Sale Agreement Date: May 27th 2019 Parties: Alterola Biotech Inc Address: 23 Golden Square, London, W1F 9JP United Kingdom (Purchaser)Share Sale Agreement • August 26th, 2019 • Alterola Biotech Inc. • Metal mining • Western Australia
In this Agreement: Agreement means the agreement constituted by this document and includes the recitals. Authorisation means any permit, approval, authorisation, consent, exemption, filing, licence, notarisation, registration, password or waiver however described and any renewal or variation to any of them. Business Day means a day that is not a Saturday, Sunday or public holiday in Namibia. Initial Cash Consideration means USD$100,000 (cash or shares) to be paid to the Vendor in accordance with clause 4.
